Pelion invests in DocMorris

DocMorris AG / Key word(s): Investment Pelion invests in DocMorris 20-May-2025 / 13:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Frauenfeld, 20 May 2025

Press release

Ad hoc announcement pursuant to Art. 53 LR

Pelion invests in DocMorris

DocMorris AG (‘DocMorris’) was informed by Pelion S.A. (‘Pelion’), the largest company active in the healthcare sector in Poland, that Pelion has acquired a stake of 9.68% in DocMorris, calculated on the basis of the future number of shares of 51,017,883 after the rights issue. Based on the number of shares before the capital increase of 14,835,093, this corresponds to a stake of 33.27%. DocMorris welcomes that Pelion has made the decision to invest in the company, and is therefore convinced of its potential, being close to the industry with a lot of experience in the pharmacy business. DocMorris had held talks with several potential strategic investors, ahead of the rights issue, including Pelion.

According to information on Pelion's website, the privately owned company is headquartered in Lodz, Poland, and has more than 12,000 employees and a turnover of over PLN 18 bn (around CHF 4 bn). Pelion is active in the wholesale of medical products (including medicines), the stationary and online sale of prescription and non-prescription medicines, the supply of hospitals and the provision of logistics services. In addition to Poland, Pelion is also active in Lithuania and Sweden.

Investors and analyst contact
Dr. Daniel Grigat, Head of Investor Relations & Sustainability
Email: [e-mail], phone: [phone]

Media contact
Torben Bonnke, Director Communications
Email: [e-mail], phone: [phone]

Agenda

19 August 2025	2025 Half-year results (conference call/webcast)
16 October 2025	Q3/2025 Trading update
20 January 2026	Sales 2025
19 March 2026	2025 Full-year results and outlook 2026 (conference call/webcast)
16 April 2026	Q1/2026 Trading update
12 May 2026	Annual General Meeting, Zurich
19 August 2026	2026 Half-year results (conference call/webcast)
15 October 2026	Q3/2026 Trading update

DocMorris